|
Volumn 9, Issue 3, 2010, Pages 241-242
|
Multimeric-001: BiondVaxs universal flu vaccine
|
Author keywords
[No Author keywords available]
|
Indexed keywords
GAMMA INTERFERON;
INFLUENZA VACCINE;
INTERLEUKIN 2;
MULTIMERIC 001;
UNCLASSIFIED DRUG;
VIRUS PROTEIN;
RECOMBINANT VACCINE;
SUBUNIT VACCINE;
ANTIBODY RESPONSE;
CELL PROLIFERATION;
CELLULAR IMMUNITY;
CYTOKINE RELEASE;
ESCHERICHIA COLI;
FERMENTATION TECHNIQUE;
FOOD AND DRUG ADMINISTRATION;
HEMAGGLUTINATION INHIBITION;
HUMAN;
INFLUENZA;
INFLUENZA VACCINATION;
INFLUENZA VIRUS;
LYMPHOCYTE ACTIVATION;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
VACCINE PRODUCTION;
VIRUS STRAIN;
ARTICLE;
CLINICAL TRIAL;
GENETICS;
IMMUNOLOGY;
INTERVIEW;
ISRAEL;
MEDICAL RESEARCH;
NUCLEOTIDE SEQUENCE;
ORTHOMYXOVIRUS;
BIOMEDICAL RESEARCH;
CLINICAL TRIALS AS TOPIC;
CONSERVED SEQUENCE;
HUMANS;
INFLUENZA VACCINES;
INFLUENZA, HUMAN;
ISRAEL;
ORTHOMYXOVIRIDAE;
VACCINES, SUBUNIT;
VACCINES, SYNTHETIC;
|
EID: 77949475051
PISSN: 14760584
EISSN: 17448395
Source Type: Journal
DOI: 10.1586/erv.10.2 Document Type: Note |
Times cited : (7)
|
References (0)
|